WO1987000865A1 - Molecular farming - Google Patents
Molecular farming Download PDFInfo
- Publication number
- WO1987000865A1 WO1987000865A1 PCT/US1986/001599 US8601599W WO8700865A1 WO 1987000865 A1 WO1987000865 A1 WO 1987000865A1 US 8601599 W US8601599 W US 8601599W WO 8700865 A1 WO8700865 A1 WO 8700865A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant cells
- dna
- transcriptional
- translational initiation
- expression cassette
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Definitions
- unicellular microorganisms which could be grown in large fermentation tanks, do not have fastidious nutrient requirements and are relatively economical to maintain.
- Bacteria such as E. coli, B. subtilis, or the like
- fungi such as yeast, Candida, filamentous fungi, or the like
- the folding and processing in a mammalian cell appears to be substantially different from these lower order organisms. Therefore, the products which are obtained from the unicellular microorganisms may not have been properly processed or folded so as to realize a substantial proportion or all of the physiological activity of the naturally occurring peptide obtained from a native host.
- SUMMARY OF THE INVENTION Efficient production of physiologically active mammalian proteins is provided by introducing functional constructs containing the mammalian structural gene into a plant cell.
- the construct is able to express the desired peptide in an isolatable form.
- the plant cells may be grown in culture or cultivated in an appropriate nutrient medium or soil and the mammalian protein harvested.
- T-DNA transformation may be employed for integration of the construct into the plant genome under conditions where the cells can be used to produce plants.
- Novel DNA sequences comprising constructs functional in plant cells for the expression of physiologically active mammalian peptides.
- the constructs provide for functional transcriptional and translational initiation and termination regulatory signals which with the construct integrated into the plant genome, provide for efficient expression of the structural gene.
- these cells or plants may be harvested, and the desired product extracted and purified in accordance with conventional techniques.
- the construct for introduction into the plant will be considered first. While the construct may be either DNA or RNA, for the most part, the construct will be DNA even though the construct may be ultimately introduced into the plant cell as RNA, such as a virus.
- RNA such as a virus.
- One significant element of the construct will be the transcriptional cassette involving the transcriptional initiation region, which may be divided into a regulatory domain and the usually proximal RNA polymerase binding domain, the structural gene coding for the mammalian peptide of interest, and a terminator region which provides for termination of transcription and translation.
- Another significant element is the regulation of expression at a particular stage of differentiation, in a particular plant part, e.g., roots, leaves, stalk, or the like.
- a polypeptide leader signal will be desirab.le which directs the product to a particular organelle. This will be of substantial significance where the organelle may be involved in the proper processing of the peptide.
- a wide variety of transcriptional initiation regions may be employed, which are inducible, e.g., tissue specific, or constitutive.
- the transcriptional initiation regions may come from the tumor-inducing plasmids of Agrobacterium, particularly the genes associated with T-DNA, or from viruses, or plants.
- T-DNA transcription initiation regions which may find use include those regions associated with octopine synthase, nopaline synthase, mannopine synthase, transcript 7, and the like.
- viral transcription initiation regions are included the caulimovirus full length promoter and the region VI promoter.
- plant transcription initiation regions are the ribulose- 1,5-bisphosphate carboxylase small subunit region, which is light inducible, or the napin or other seed protein region, for formation in seed.
- the transcription initiation regions may be isolated from their natural sites in a host or may be sequenced and synthesized so as to have the same or substantially the same sequence as the wild-type region. Where inducible regulation is desired, domains may be obtained from different sources, so that a regulatory domain may be obtained from one source and joined to an RNA polymerase binding domain from a different source. In this manner, one may provide for the use of strong RNA polymerase binding domain associ ⁇ ated with one structural gene, while having a regulatory domain associated with a different structural gene. These hybrid regulatory regions may find particular use where one wishes to induce the production of the desired gene at a particular phase in the growth of the plant or to have the product located in a particular plant part, such as seed, leaves, or the like.
- Any transcriptional termination regulatory region may be used which is functional in plants, e.g., prokaryotic or eukaryotic, from T-DNA, plants, viruses or mammals.
- the structural gene may be any mammalian gene of interest, which includes mammalian viral pathogen genes.
- a wide variety of genes have been isolated and shown to be capable of production in unicellular micro- organisms, to various degrees of biological activity and efficiencies, and in mammalian cells, with the ever present concern that the mammalian cells are transformed cells, so that any product must be carefully purified to ensure the complete absence of any nucleic acid contaminant.
- Structural genes of interest include ⁇ -, ⁇ - and ⁇ -interferons, immunoglobulins, with the struc ⁇ tural genes coding for the light and heavy chains and desirably assembly occurring in the plant cell, lympho- kines, such as interleukins 1, 2 and 3, growth factors, including insulin-like growth factor, epidermal growth factor, platelet derived growth factor, transforming growth factor- ⁇ , - ⁇ , etc., growth hormone, insulin, collagen plasminogen activator, blood factors, such as factors I to XII, histocompatibility antigens, enzymes, or other mammalian proteins, particularly human proteins.
- lympho- kines such as interleukins 1, 2 and 3
- growth factors including insulin-like growth factor, epidermal growth factor, platelet derived growth factor, transforming growth factor- ⁇ , - ⁇ , etc., growth hormone, insulin, collagen plasminogen activator, blood factors, such as factors I to XII, histocompatibility antigens
- antigens associated with viral pathogens include the core and envelope proteins of leukemia and lymphotropic retroviruses, such as HTLV-I, -II and -III, feline leukemia virus, etc., surface antigens of herpes simplex virus, hepatitis B virus, adenovirus, and the like.
- Peptides of interest other than those indica ⁇ ted above will be peptides which may be administered physiologically, where growth in plants diminishes the probability of contaminants causing an adverse response upon administration to a mammalian host.
- Plants may also find use in preparing other proteins than to be administered to a host, where the mammalian protein, such as an enzyme, may require folding and/or processing that is unavailable in unicellular microorganisms. Not only may plants be used to prepare the mature peptide, but in many instances it may be desirable to prepare the precursor, which may require cleavage and assembly, either endogenous or exogenous to the plant.
- Peptides can be prepared having a naturally occurring transit or leader peptide or a transit or leader peptide from a plant peptide. The transit peptide will serve to subject the entire peptide product to the processing and maturing of the peptide. Such processing may include specific peptide cleavage, e.g., removal of the transit peptide, glycosylation at glycosylation sites, folding with appropriate formation of disulfide linkages.
- any convenient terminator may be employed which provides for efficient termination in conjunction with a particular transcriptional initiation region.
- the terminator may be the terminator region normally associated with the transcriptional initiation region or associated with a different transcriptional initia ⁇ tion region, so long as the region is functional in plants.
- the expression construct or cassette will usually be joined to a marker.
- the marker will allow for either screening or selection, usually selection.
- a number of different antibiotic resistance genes are known that can find use in plants to serve as markers. These genes include enzymes providing resistance to kanamycin, chloramphen- icol, G418, gentamycin, and the like. These genes will have transcriptional and translational initiation and termination regulatory regions that may be the same or different from the regions employed for the structural gene of interest. Usually constitutive expression will be provided, rather than inducible expression.
- the cassette and marker depending upon the manner in which the DNA construct will be introduced into the plant cell, other sequences may be necessary. Where the Agrobacterium tumor- inducing system is to be employed, one or both of the T-DNA boundaries of a Ti- or Ri-plasmid will be present, particularly the right boundary region. Each boundary region will generally be of about 1 to 1.5kbp.
- T-DNA may then be employed in a variety of ways.
- the construct may be introduced into an appropriate Agrobacterium strain carrying the tumor-inducing plasmid, whereby the construct will become integrated into the tumor-inducing plasmid and may then be transferred to plant cells.
- the construct may be joined to a broad spectrum replication system, such as a Pi incompatibility replication system and transformed into an Agrobacterium containing an armed or disarmed tumor-inducing plasmid. Integration will occur and transfer to the plant cell of the construct along with other genes and markers.
- armed tumor-inducing plasmid Ti or Ri T-DNA containing plasmid
- genes conferring tumor formation will be transferred, so that galls may form.
- disarmed tumor plasmids lacking T-DNA
- the tumor-causing genes cannot be transferred and gall formation is not encountered.
- a transposon may be employed containing the construct and the gene coding for transposase, such as in the Ac-Ds system.
- a viral system may be employed which provides for integration into the host genome.
- Transfer of the DNA construct into the plant cell may be by infection with A. tumefaciens or A. rhizogenes, microinjection, liposome fusion, viral infection, or the like.
- A. tumefaciens or A. rhizogenes A. rhizogenes
- microinjection microinjection
- liposome fusion liposome fusion
- viral infection or the like.
- the particular manner in which the DNA is introduced into the plant cell for integration is not critical to this invention.
- the construct will be joined to a prokaryotic replication system, for example, a system functional in E_. coli, so as to allow for cloning at the various stages of preparation of the construct.
- a prokaryotic replication system for example, a system functional in E_. coli, so as to allow for cloning at the various stages of preparation of the construct.
- a wide variety of replication systems are available, both plasmid and phage, such as ColEl, ⁇ , etc.
- Plant cells which are employed may be either monocots or dicots and will be chosen in accordance with the manner in which the desired gene is to be produced and harvested. Plants which may find use include tobacco, sunflower, corn, sugar cane, soybean, tomato, alfalfa, mustard, sugar beet, rapeseed, etc.
- the product may be found in plant parts such as seed, leaves, fruit, roots, stalks, tubers, or combinations thereof.
- the peptide of interest may be the sole purpose for growing the plant or be an additional product.
- DNA sequences may be detected by employing probes, which may be designed based on known amino acid sequences or prior isolation of all or fragments of mRNA or chromosomal DNA.
- the sequences may be restriction mapped or sequenced and the entire gene obtained by various techniques, such as walking, using a plurality of primers, or the like.
- Once the sequence has been isolated, it may be ligated to other sequences, either directly or through linkers, where the linkers may provide no or portions of coding sequences.
- Various strategies may be devised based on available restriction sites, the absence of restriction sites, the ability to introduce restriction sites, the availability of particular fragments, the presence of sequences which require excision, and the like.
- the particular strategy will be dependent upon the gene which is employed, the particular regulatory systems, the availability of vectors having one or more of the desired sequences, as well as other practical considerations.
- the manner in which the construct is introduced into plants may be varied widely. This has already been indicated by virtue of the different sequences which may be included in the construct.
- Of particular interest is the presence of T-DNA for integration in conjunction with the vir genes of the Ti-plasmid which may be present on a plasmid other than the plasmid containing the foreign gene.
- the necessary genetic capability for integration into the plant cell can be provided, in conjunction with infection with Agrobacterium or introduction of the DNA by other means. Descriptions of introduction of DNA into plants may be found in Pedersen et al.
- the transformed plant cells will then be grown in appropriate nutrient medium to provide for selected calli, where plant cells or protoplasts have been modified. Once the calli has formed, the medium may then be changed to encourage root and shoot formation and the resulting shoots transferred to appropriate growth medium for growth of plants.
- the plants or plant parts e.g., seeds, fruit or the like
- the desired product isolated in accordance with conventional ways. Thereafter, the gene may be regenerated from seeds, so that the process of regeneration from calli need not be repeated.
- the plant may be ground and extracted with appropriate solvents, chro atographed, crystallized, solvent extracted, etc.
- the crude product may then be purified in accordance with the nature of the product.
- the plant part is edible, such as fodder which could include ' nutritional qualities, such as bovine growth hormone, seed, nuts, fruit, and vegetables, which could include proteins involved in the regulation of digestion, or the like.
- fodder which could include ' nutritional qualities, such as bovine growth hormone, seed, nuts, fruit, and vegetables, which could include proteins involved in the regulation of digestion, or the like.
- kanamycin resistance was obtained by inserting the Bglll-PstI fragment of the APHII gene into the BamHI-PstI site (pCGN546X) . This procedure reassembles the APHII gene, so that EcoRI sites flank the gene. An ATG codon was upstream from and out of reading frame with the ATG initiation codon of APHII. The undesired ATG was avoided by inserting a Sau3A-PstI fragment from the 5'-end of APHII, which fragment lacks the superfluous ATG, into the BamHI-PstI site of pCGN546W to provide plasmid pCGN550.
- pCGN451 contains an octopine synthase cassette for expression, to provide pCGN552.
- pCGN451 includes an octopine cassette which contains about 1556bp of the 5' non-coding region fused via an EcoRI linker to the 3' non-coding region of the octopine synthase gene of pTiA6.
- the pTi coordinates are 11,207 to 12,823 for the 3' region and 13,643 to 15,208 for the 5' region as defined by Barker et al. , Plant Mol. Biol. (1983) 2_:325.
- the 5* fragment was obtained as follows. A small subcloned fragment containing the 5' end of the coding region, as a BamHI-EcoRI fragment was cloned in pBR322 as plasmid pCGN407. The BamHI-EcoRI fragment has an XmnI site in the coding region, while pBR322 has two XmnI sites. pCGN407 was digested with XmnI, resected with Bal31 nuclease and EcoRI linkers added to the fragments. After EcoRI and BamHI digestion, the fragments were size fractionated, the fractions cloned and sequenced.
- the entire coding region and lObp of the 5 1 non-translated sequences had been removed leaving the 5' non-transcribed region, the mRNA cap site and 16bp of the 5' non-translated region (to a BamHI site) intact.
- This small fragment was obtained by size fractionation on a 7% acrylamide gel and fragments approximately 130bp long eluted.
- This size fractionated DNA was ligated into M13mp9 and several clones sequenced and the sequence compared to the known sequence of the octopine synthase gene.
- the Ml3 construct was designated pl4, which plasmid was digested with Ba HI and EcoRI to provide the small fragment which was ligated to a Xhol to BamHI fragment containing upstream 5' sequences from pTiA6 (Garfinkel and Nester, J. Bacteriol. (1980) 144:732) and to an EcoRI to Xhol fragment containing the 3' sequences. The resulting Xhol fragment was cloned into the Xhol site of a pUC8 derivative, designated pCGN426.
- This plasmid differs from pUC8 by having the sole EcoRI site filled in with DNA polymerase I, and having lost the PstI and Hindlll site by nuclease contamination of Hindi restriction endonuclease, when a Xhol linker was inserted into the unique Hindi site of pUC8.
- the resulting plasmid pCGN451 has a single EcoRI site for the insertion of protein coding sequences between the 5' non-coding region (which contains l,550bp of 5' non-transcribed sequence including the right border of the T-DNA, the mRNA cap site and 16bp of 5' non-translated sequence) and the 3' region (which contains 267bp of the coding region, the stop codon, 196bp of 3' non-translated DNA, the polyA site and l,153bp of 3' non-transcribed sequence).
- pCGN451 also provides the right T-DNA border.
- the resulting plasmid pCGN451 having the ocs 5' and the ocs 3' in the proper orientation was digested with EcoRI and the EcoRI fragment from pCGN551 containing the intact kanamycin resistance gene inserted into the EcoRI site to provide pCGN 552 having the kanamycin resistance gene in the proper orientation.
- This ocs/KAN gene was used to provide a selectable marker for the trans type binary vector pCGN587.
- the 5' portion of the engineered octopine synthase promoter cassette consists of TiA6 DNA from the Xhol at bp 15208-13644 (Barker's numbering), which also contains the T-DNA boundary sequence (border) implicated in T-DNA transfer.
- the ocs/KAN gene from pCGN552 provides a selectable marker as well the right border.
- the left boundary region was recloned from the Hindlll-EcoRI fragment as a KpnI-EcoRI fragment in pCGN565 to provide pCGN580.
- pCGN565 is a cloning vector based on pUC8-Cm, but containing pUC18 linkers.
- pCGN580 was linearized with BamHI and used to replace the smaller BJ.II fragment of pVCK102 (Knauf and Nester, Plasmid (1982) £:45), creating pCGN585.
- pCGN587 was obtained.
- pCGN807 is derived from pBR322, contains the tetracycline resistance gene, has about 300bp of a sequence including the trp promoter 5' to a 750bp sequence including all of the murine ⁇ -interferon structural cDNA and a 3'-untranslated region, with the gene described in Gray and Goeddel, Proc. Natl. Acad. Sci. USA (1983) £ :5842-5846.
- the promoter and gene are an EcoRI fragment of about 834bp.
- pCGN807 was digested with EcoRI and Hpal which fragment was inserted into pEMBL18+, which had been digested with EcoRI and Smal creating pCGN808.
- pEMBLl8+ differs from the pEMBL plasmids in having the pUCl ⁇ linker inserted into the 8-galactosidase gene.
- pCGN808 was digested with EcoRI and BamHI to provide a 540bp fragment which was inserted into pCGN46 which had been digested with EcoRI and BamHI to provide for the murine ⁇ -interferon cDNA gene to be in the proper orientation in relation to the mannopine synthase (mas) 5' transcription initiation region and the ocs 3* transcription termination region (pCGN809) .
- pCGN40 was digested with EcoRV and EcoRI where the _E___c___o_RV site is in the T-DNA, while ⁇ the EcoRI site is in the polylinker of pUC19 to provide a fragment having the P ⁇ . region.
- pCGN451 containing the octopine synthase cassette was digested with Smal and EcoRI and the larger fragment isolated from which the octopine synthase 5' region had been removed.
- the EcoRV-EcoRI Pw ao region was substituted into pCGN451 for the octopine synthase 5' region, where the transcriptional initiation and termination regions were separated by a polylinker to provide pCGN46.
- pCGN809 was transformed into an E. coli polAl mutant containing pCGN587.
- the two plasmids pCGN587 and pCGN809 share two regions of homology where recombination can occur: at the ocs 3* regions of the APHII gene and the ⁇ -interferon gene, and at the pUC origins of the two plasmids, recombination at either site results in a plasmid containing both the ⁇ -interferon gene and the APHII gene as intact expression units.
- the pCGN809 plasmid which has a pUC origin of replication, can only survive by integration into the pCGN587 plasmid, which has a wide host range replication system. Since the pCGN809 construct has ampicillin resistance, the chimeric plasmid pCGN810 can be selected.
- the transformed E. coli host was grown in a nutrient medium containing lOO ⁇ g/ml ampicillin and surviving clones isolated. Plasmid pCGN810 was then mated into A. tumefaciens C58 (Watson e al.. , J_ j _ Bacteriol.
- pCGN810 was also mated into A. tumefaciens K61, which contains a disarmed Ti-plasmid, as compared to C58 which has the genetic capability for nopaline expression, and is an armed Ti-plasmid.
- the transformed Agrobacterium was selected with carbenicillin (50ug/ml) and streptomycin (150yg/ml) at 30°C for two to three successive streak outs. After growth under selection, DNA was isolated and restricted with BamHI and EcoRI and verified by probe hybridization.
- the cloned pCGN808 was used as the nick-translated probe and confirmed the presence of a 565bp ⁇ -: ' .nterferon fragment in both the expression vector p GN46 and the T-DNA plasmid pCGN587 in armed and disarmed Agrobacterium.
- pCGN810 constructs in both C58 and K61 were co ultivated with Nicotiana tabacum xanthii protoplasts and clumps of transformed cells which were selected in lOO ⁇ g/ml kanamycin were transferred to solid media containing kanamycin (lOO ⁇ g/ml) for further growth and regeneration into plants.
- Tobacco leaf disks were cocultivated with pCGNS 10 in C58 and K61 Agrobacterium strains and the disk_ transferred to selective media with kanamycin (100'ig/ml) for growth to callus.
- tumefaciens C58 (pCGN810)
- a visible band ran at the same size as the positive control ⁇ -interferon samples.
- Analysis of the mRNA obtained after an oligo-dT prep of total RNA was performed using nick-translated isolated gene fragments to the Tn5 kanamycin gene (in pCGN587) and the ⁇ -interferon fragment (in pCGN808) .
- the Northern data showed a message in both pCGN587 and pCGN810 mRNA preps which hybridize to the kanamycin fragment.
- Samples were prepared and bioassayed for murine ⁇ -interferon.
- the samples were prepared as follows: To frozen tobacco tissue from tissue culture (1.6 or l.Og) ground in liquid nitrogen was added 5 or 2.5ml, respectively, extraction buffer (1M NaCl, 25mg/ml BSA, lOmM DTT, lOmM cysteine, 20mM NaP0 4 , pH 7.4) and grinding continued until the mixture was liquid.
- the liquid was then centrifuged twice at 16K rpm for 20min, transferring the liquid to a fresh tube after the first separation.
- the sample was then diluted to 5ml and 0.5ml control pore glass beads (CPG) (washed and autoclaved) were added and the mixture agitated at 4°C for 4hr.
- CPG control pore glass beads
- the mixture was then loaded onto a silane treated Pasteur pipette column, the column washed with 3ml 20mM NaPO., 1M NaCl and the product eluted with 5ml 1M NaCl, 30% ethylene glycol.
- the material eluted from the column was then dialyzed overnight against 20mM NaPO., 1M NaCl. Dialysis buffer ⁇ was changed once at 3hr.
- the dialysed sample was concentrated with a Millipore immersible-CX 10,000 ultrafilter to less than about 1ml and then a series of dilutions with BSA buffer (1M NaCl, 20mM NaP0 4 , pH 7.4, 25mg/ml BSA) performed. Comparison samples were made from transformed and untransformed tobacco, where no ⁇ -interferon gene was introduced, where the tissue was or was not supplemented with ⁇ -interferon. The following table indicates the results.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Surface Treatment Of Optical Elements (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE8686905070T DE3687705T2 (en) | 1985-07-29 | 1986-07-29 | MOLECULAR BREEDING. |
AT86905070T ATE85361T1 (en) | 1985-07-29 | 1986-07-29 | MOLECULAR BREEDING. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/760,236 US4956282A (en) | 1985-07-29 | 1985-07-29 | Mammalian peptide expression in plant cells |
US760,236 | 1985-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1987000865A1 true WO1987000865A1 (en) | 1987-02-12 |
Family
ID=25058500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1986/001599 WO1987000865A1 (en) | 1985-07-29 | 1986-07-29 | Molecular farming |
Country Status (8)
Country | Link |
---|---|
US (5) | US4956282A (en) |
EP (1) | EP0233915B1 (en) |
JP (1) | JPS63500425A (en) |
AT (1) | ATE85361T1 (en) |
AU (1) | AU603063B2 (en) |
CA (1) | CA1340696C (en) |
DE (1) | DE3687705T2 (en) |
WO (1) | WO1987000865A1 (en) |
Cited By (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0204590A2 (en) * | 1985-04-22 | 1986-12-10 | Institut National De La Recherche Agronomique (Inra) | T-DNA promoters of the Ri plasmid |
EP0289478A2 (en) * | 1987-04-27 | 1988-11-02 | Monsanto Company | Gentamicin marker genes for plant transformation |
WO1989003887A1 (en) * | 1987-10-20 | 1989-05-05 | Plant Genetic Systems N.V. | A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants |
EP0318341A1 (en) * | 1987-10-20 | 1989-05-31 | Plant Genetic Systems, N.V. | A process for the production of transgenic plants with increased nutritional value via the expression of modified 2S storage albumins in said plants |
EP0319353A1 (en) * | 1987-10-20 | 1989-06-07 | Plant Genetic Systems N.V. | A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants |
WO1990001551A1 (en) * | 1988-07-29 | 1990-02-22 | Washington University School Of Medicine | Producing commercially valuable polypeptides with genetically transformed endosperm tissue |
WO1990002484A1 (en) * | 1988-09-06 | 1990-03-22 | Washington University | Oral immunization by transgenic plants |
WO1991002066A1 (en) * | 1989-07-26 | 1991-02-21 | Mogen International N.V. | Production of heterologous proteins in plants and plant cells |
WO1991006320A1 (en) * | 1989-10-27 | 1991-05-16 | Scripps Clinic And Research Foundation | Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
WO1991013993A1 (en) * | 1990-03-05 | 1991-09-19 | The Upjohn Company | Protein expression via seed specific regulatory sequences |
EP0449375A2 (en) * | 1990-03-23 | 1991-10-02 | Gist-Brocades N.V. | The expression of phytase in plants |
EP0449376A2 (en) * | 1990-03-23 | 1991-10-02 | Gist-Brocades N.V. | Production of enzymes in seeds and their use |
WO1992001042A1 (en) * | 1990-07-06 | 1992-01-23 | Novo Nordisk A/S | Transgenic plants expressing industrial enzymes |
AU628962B2 (en) * | 1989-04-10 | 1992-09-24 | Medex, Inc. | Catheter with needle guard |
US5428146A (en) * | 1988-11-07 | 1995-06-27 | Max-Planck-Gesellschaft Zur Forderung | Wound-stimulated DNA-sequence from solanum tuberosum and its use |
US5484719A (en) * | 1991-08-26 | 1996-01-16 | Edible Vaccines, Inc. | Vaccines produced and administered through edible plants |
EP0723019A1 (en) * | 1987-10-20 | 1996-07-24 | Plant Genetic Systems N.V. | A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants |
US5543576A (en) * | 1990-03-23 | 1996-08-06 | Mogen International | Production of enzymes in seeds and their use |
US5589615A (en) * | 1988-10-14 | 1996-12-31 | Plant Genetic Systems N.V. | Process for the production of transgenic plants with increased nutritional value via the expression of modified 2S storage albumins |
US5593963A (en) * | 1990-09-21 | 1997-01-14 | Mogen International | Expression of phytase in plants |
US5623067A (en) * | 1987-10-20 | 1997-04-22 | Plant Genetic Systems, N.V. | Seed-specific promoter region |
US5677474A (en) * | 1988-07-29 | 1997-10-14 | Washington University | Producing commercially valuable polypeptides with genetically transformed endosperm tissue |
WO1998021348A1 (en) * | 1996-11-12 | 1998-05-22 | Battelle Memorial Institute | Method of producing human growth factors from whole plants or plant cell cultures |
WO1999009187A1 (en) * | 1995-05-16 | 1999-02-25 | Lefaivre Francis E | Large scale production of human or animal proteins using plant bioreactors |
US5959177A (en) * | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
US5981835A (en) * | 1996-10-17 | 1999-11-09 | Wisconsin Alumni Research Foundation | Transgenic plants as an alternative source of lignocellulosic-degrading enzymes |
US6136320A (en) * | 1991-08-26 | 2000-10-24 | Prodigene, Inc. | Vaccines expressed in plants |
WO2001031044A1 (en) * | 1999-10-26 | 2001-05-03 | Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. | Gonadotrophins in plants |
WO2001042441A2 (en) * | 1999-12-08 | 2001-06-14 | International Centre For Genetic Engineering And Biotechnology | Plastid transformation |
US6696620B2 (en) | 2000-05-02 | 2004-02-24 | Epicyte Pharmaceutical, Inc. | Immunoglobulin binding protein arrays in eukaryotic cells |
US6818803B1 (en) | 1997-06-26 | 2004-11-16 | Wisconsin Alumni Research Foundation | Transgenic plants as an alternative source of lignocellulosic-degrading enzymes |
US6852319B2 (en) | 1989-10-27 | 2005-02-08 | The Scripps Research Institue | Method of use of transgenic plant expressed antibodies |
WO2006005362A1 (en) * | 2004-07-13 | 2006-01-19 | Paion Deutschland Gmbh | Production of mammalian proteins in plant cells |
US6995014B1 (en) | 1989-10-27 | 2006-02-07 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
US7033627B2 (en) | 1990-03-23 | 2006-04-25 | Syngenta Mogen B.V. | Production of enzymes in seeds and their use |
US7037722B1 (en) | 1989-10-27 | 2006-05-02 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
EP1772518A3 (en) * | 1999-10-26 | 2007-04-18 | Plant Research International B.V. | Mammalian-type glycosylation in plants |
US7601891B2 (en) | 2002-03-19 | 2009-10-13 | Plant Research International B.V. | Optimizing glycan processing plants |
US8106169B2 (en) | 2002-11-27 | 2012-01-31 | Phyton Holdings, Llc | Plant production of immunoglobulins with reduced fucosylation |
US8241909B2 (en) | 1998-12-09 | 2012-08-14 | Phyton Holdings, Llc | Method for manufacturing glycoproteins having human-type glycosylation |
US8309795B2 (en) | 2001-01-19 | 2012-11-13 | Phyton Holdings, Llc | Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
US8492613B2 (en) | 2002-03-19 | 2013-07-23 | Stichting Dienst Landbouwkundig Onderzoek | GNTIII expression in plants |
US8829276B2 (en) | 2007-04-17 | 2014-09-09 | Stichting Dienst Landbouwkundig Onderzoek | Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases |
Families Citing this family (162)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4956282A (en) * | 1985-07-29 | 1990-09-11 | Calgene, Inc. | Mammalian peptide expression in plant cells |
US6774283B1 (en) * | 1985-07-29 | 2004-08-10 | Calgene Llc | Molecular farming |
US20040093646A1 (en) * | 1988-02-26 | 2004-05-13 | Erwin Robert L. | Production of lysosomal enzymes in plants by transient expression |
US6846968B1 (en) * | 1988-02-26 | 2005-01-25 | Large Scale Biology Corporation | Production of lysosomal enzymes in plants by transient expression |
US7705215B1 (en) | 1990-04-17 | 2010-04-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US6803499B1 (en) | 1989-08-09 | 2004-10-12 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
EP1090999B1 (en) * | 1989-08-10 | 2011-01-19 | Bayer BioScience N.V. | Plant with modified flowers |
US5658772A (en) * | 1989-12-22 | 1997-08-19 | E. I. Du Pont De Nemours And Company | Site-specific recombination of DNA in plant cells |
US6025545A (en) * | 1990-01-22 | 2000-02-15 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US6329574B1 (en) | 1990-01-22 | 2001-12-11 | Dekalb Genetics Corporation | High lysine fertile transgenic corn plants |
US6946587B1 (en) * | 1990-01-22 | 2005-09-20 | Dekalb Genetics Corporation | Method for preparing fertile transgenic corn plants |
US6777589B1 (en) | 1990-01-22 | 2004-08-17 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
JP3209744B2 (en) | 1990-01-22 | 2001-09-17 | デカルブ・ジェネティクス・コーポレーション | Transgenic corn with fruiting ability |
US5969214A (en) * | 1990-06-11 | 1999-10-19 | Calgene, Inc. | Glycogen biosynthetic enzymes in plants |
US5750875A (en) * | 1990-06-11 | 1998-05-12 | Stalker; David M. | Glycogen biosynthetic enzymes in plants |
US6395966B1 (en) * | 1990-08-09 | 2002-05-28 | Dekalb Genetics Corp. | Fertile transgenic maize plants containing a gene encoding the pat protein |
US5306862A (en) * | 1990-10-12 | 1994-04-26 | Amoco Corporation | Method and composition for increasing sterol accumulation in higher plants |
EP0636181B1 (en) * | 1991-02-25 | 2000-11-29 | Zeneca Limited | Use of a gene encoding oxalate oxidase for the transformation of plants |
GB9108386D0 (en) | 1991-04-19 | 1991-06-05 | Agricultural Genetics Co | Modified plant viruses as vectors |
US6034298A (en) * | 1991-08-26 | 2000-03-07 | Prodigene, Inc. | Vaccines expressed in plants |
US20010053367A1 (en) * | 1991-08-26 | 2001-12-20 | Prodigene, Inc. | Vaccines expressed in plants |
US5418153A (en) * | 1992-04-28 | 1995-05-23 | Nihon Nohyaku Co., Ltd. | Process for production of exogenous gene or its product in plant cells |
JP3510625B2 (en) * | 1992-06-30 | 2004-03-29 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | DN-carbamoyl-amino acid amide hydrolase and hydantoinase |
JPH08503851A (en) * | 1992-11-30 | 1996-04-30 | ゼネカ・リミテッド | Oxalate decarboxylase |
JP3183407B2 (en) * | 1993-07-01 | 2001-07-09 | カリフォルニア インスティテュート オブ テクノロジー | Plants with a modified response to ethylene |
US5689055A (en) * | 1993-07-01 | 1997-11-18 | California Institue Of Technology | Plants having modified response to ethylene |
US6281411B1 (en) | 1993-08-25 | 2001-08-28 | Dekalb Genetics Corporation | Transgenic monocots plants with increased glycine-betaine content |
US6118047A (en) | 1993-08-25 | 2000-09-12 | Dekalb Genetic Corporation | Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction |
US6326527B1 (en) * | 1993-08-25 | 2001-12-04 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
US5693506A (en) * | 1993-11-16 | 1997-12-02 | The Regents Of The University Of California | Process for protein production in plants |
JPH09508786A (en) * | 1993-12-09 | 1997-09-09 | ザ、テクサス、エイアンドエム、ユーニヴァーサティ、システィム | Transformation of Agrobacterium tumefaciens of Basou species |
US6080560A (en) * | 1994-07-25 | 2000-06-27 | Monsanto Company | Method for producing antibodies in plant cells |
US6140075A (en) * | 1994-07-25 | 2000-10-31 | Monsanto Company | Method for producing antibodies and protein toxins in plant cells |
US5723764A (en) * | 1995-06-07 | 1998-03-03 | Pioneer Hi-Bred International, Inc. | Cellulose synthesis in the storage tissue of transgenic plants |
WO1997004123A1 (en) * | 1995-07-19 | 1997-02-06 | Gel Tech Group Inc. | Collagen compound production in plants |
US6020169A (en) * | 1995-07-20 | 2000-02-01 | Washington State University Research Foundation | Production of secreted foreign polypeptides in plant cell culture |
ATE426031T1 (en) * | 1995-09-14 | 2009-04-15 | Virginia Tech Intell Prop | PRODUCTION OF LYSOSOMAL ENZYMES IN PLANT EXPRESSION SYSTEMS |
AU6976296A (en) * | 1995-09-15 | 1997-04-01 | John A Howard | Expression cassettes and methods for delivery of animal vaccines |
US5767379A (en) * | 1995-11-06 | 1998-06-16 | John Howard | Commercial production of avidin in plants |
US5824870A (en) * | 1995-11-06 | 1998-10-20 | Baszczynski; Chris | Commercial production of aprotinin in plants |
US20020124278A1 (en) * | 1996-02-09 | 2002-09-05 | Niu Man C. | Methods for effectuating mRNA transfer of genetic information between species and product of the same |
US5855881A (en) * | 1996-02-22 | 1999-01-05 | Loike; John D. | Mammalian alcohol dehydrogenase and aldehyde dehydrogenase production in plants |
US6042832A (en) * | 1996-08-28 | 2000-03-28 | Thomas Jefferson University | Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins |
WO1998010062A1 (en) * | 1996-09-03 | 1998-03-12 | Monsanto Company | Monocot seed gene expression system |
US7361331B2 (en) * | 1996-10-18 | 2008-04-22 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food | Plant bioreactors |
FR2757874B1 (en) * | 1996-12-17 | 2003-04-25 | Biocem | RECOMBINANT COLLAGENS AND DERIVED PROTEINS PRODUCED BY PLANTS, THEIR METHODS OF OBTAINING AND THEIR USES |
AU2217897A (en) * | 1997-03-20 | 1998-10-12 | Gel Tech Group Inc. | Mammalian alcohol dehydrogenase and aldehyde dehydrogenase production in plants |
US6639050B1 (en) | 1997-07-21 | 2003-10-28 | Ohio University | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
US7378506B2 (en) * | 1997-07-21 | 2008-05-27 | Ohio University | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
US20030204864A1 (en) * | 2001-02-28 | 2003-10-30 | Henry Daniell | Pharmaceutical proteins, human therapeutics, human serum albumin, insulin, native cholera toxic b submitted on transgenic plastids |
US7741536B2 (en) | 1997-08-07 | 2010-06-22 | University Of Central Florida Research Foundation, Inc. | Expression of human serum albumin in plastids |
EP1002115B9 (en) | 1997-08-07 | 2008-12-03 | Auburn University | Universal chloroplast integration and expression vectors and transformed plants |
US7161064B2 (en) * | 1997-08-12 | 2007-01-09 | North Carolina State University | Method for producing stably transformed duckweed using microprojectile bombardment |
US6040498A (en) * | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
CA2303759A1 (en) * | 1997-09-16 | 1999-03-25 | Cropdesign N.V. | Cyclin-dependent kinase inhibitors and uses thereof |
US7265267B1 (en) * | 1997-09-16 | 2007-09-04 | Cropdesign N.V. | Cyclin-dependent kinase inhibitors and uses thereof |
US6777546B2 (en) * | 1997-10-07 | 2004-08-17 | Loma Linda University | Methods and substances for preventing and treating autoimmune disease |
US20050186219A1 (en) * | 1997-10-07 | 2005-08-25 | Langridge William H. | Transgenic plant-based vaccines |
US20050241024A1 (en) * | 1997-10-07 | 2005-10-27 | Langridge William H | Transgenic plant-based vaccines |
US7422747B2 (en) * | 1997-10-07 | 2008-09-09 | Loma Linda University | Transgenic plant-based vaccines |
US7655777B2 (en) * | 1997-11-24 | 2010-02-02 | Monsanto Technology Llc | Nucleic acid molecules associated with the tocopherol pathway |
US7572902B2 (en) * | 1997-12-09 | 2009-08-11 | Monsanto Technology Llc | Nucleic acid molecules seq id No. 16372 and other molecules associated with plants |
US20080256663A1 (en) * | 1997-11-24 | 2008-10-16 | Andersen Scott E | Nucleic acid molecules and other molecules associated with plants |
US7625738B1 (en) | 1997-11-24 | 2009-12-01 | Monsanto Technology Llc | Nucleic acid molecules encoding a ferrochelatase enzyme or fragment thereof |
US7919608B2 (en) * | 1997-11-24 | 2011-04-05 | Monsanto Technology Llc | Nucleic acid molecules and other molecules associated with plants |
US6426185B1 (en) * | 1998-01-16 | 2002-07-30 | Large Scale Biology Corporation | Method of compiling a functional gene profile in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in an anti-sense orientation |
US20030027173A1 (en) * | 1998-01-16 | 2003-02-06 | Della-Cioppa Guy | Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host |
US6468745B1 (en) | 1998-01-16 | 2002-10-22 | Large Scale Biology Corporation | Method for expressing a library of nucleic acid sequence variants and selecting desired traits |
US6303848B1 (en) | 1998-01-16 | 2001-10-16 | Large Scale Biology Corporation | Method for conferring herbicide, pest, or disease resistance in plant hosts |
US20060253933A1 (en) * | 1998-02-10 | 2006-11-09 | Brown Sherri M | Nucleic acid molecules and other molecules associated with the gibberellin pathway |
US20100251425A9 (en) | 1998-05-15 | 2010-09-30 | University Of Central Florida | Expression of human interferon in transgenic chloroplasts |
WO2001072959A2 (en) * | 2000-03-01 | 2001-10-04 | Auburn University | Plastid transformation vectors for expressing human proteins in plants |
US6117797A (en) * | 1998-09-03 | 2000-09-12 | Micron Technology, Inc. | Attachment method for heat sinks and devices involving removal of misplaced encapsulant |
AU6166499A (en) * | 1998-09-30 | 2000-04-17 | Regents Of The University Of California, The | Inhibition of farnesyltransferase activity in plants |
US6696619B1 (en) * | 1998-11-05 | 2004-02-24 | Omolayo O. Famodu | Plant aminoacyl-tRNA synthetases |
MXPA01006457A (en) * | 1998-12-22 | 2002-04-24 | Nat Research Council | Transgenic plants and methods for production thereof. |
US6515206B1 (en) * | 1998-12-23 | 2003-02-04 | Calgene Llc | Plastid transformation of Brassica |
US6982363B1 (en) * | 1999-02-10 | 2006-01-03 | E.I. Du Pont De Nemours And Company | UDP-glucose modifiers |
US6835868B1 (en) | 1999-03-17 | 2004-12-28 | University Of Victoria Innovation And Development Corporation | Transgenic plants expressing dermaseptin peptides providing broad spectrum resistance to pathogens |
US20070011783A1 (en) * | 1999-05-06 | 2007-01-11 | Jingdong Liu | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
US20030233670A1 (en) * | 2001-12-04 | 2003-12-18 | Edgerton Michael D. | Gene sequences and uses thereof in plants |
US7868149B2 (en) * | 1999-07-20 | 2011-01-11 | Monsanto Technology Llc | Plant genome sequence and uses thereof |
US7560542B2 (en) * | 1999-05-07 | 2009-07-14 | Monsanto Technology Llc | Nucleic acid molecule SEQ ID NO. 68811 and other molecules associated with plants |
WO2000068392A1 (en) | 1999-05-11 | 2000-11-16 | The Board Of Trustees Of The University Of Illinois | Plant-derived antigens against respiratory syncytial virus |
US20070150978A1 (en) * | 1999-05-17 | 2007-06-28 | Byrum Joseph R | Nucleic acid molecules and other molecules associated with plants |
US6395962B1 (en) | 1999-06-22 | 2002-05-28 | University Of South Carolina | Enhancing expression of a silenced target sequence in plants using plant viral enhancers and amplicons |
US20040111765A1 (en) * | 1999-06-25 | 2004-06-10 | Oishi Karen K. | Production of urokinase in plant-based expression systems |
USRE46192E1 (en) | 1999-07-20 | 2016-11-01 | Monsanto Technology Llc | Rice metallothionein promoters |
US8058516B2 (en) | 2000-07-19 | 2011-11-15 | Monsanto Technology Llc | Rice metallothionein promoters |
US7365185B2 (en) * | 2000-07-19 | 2008-04-29 | Monsanto Technology Llc | Genomic plant sequences and uses thereof |
US6916971B1 (en) * | 1999-07-30 | 2005-07-12 | Rebecca E. Cahoon | Polynucleotides encoding aminolevulinic acid biosynthetic enzymes |
US20060242729A1 (en) * | 1999-07-30 | 2006-10-26 | Cahoon Edgar B | Polynucleotides encoding proteins involved in plant metabolism |
US7557201B2 (en) * | 1999-09-21 | 2009-07-07 | Monsanto Technology Llc | Nucleic acid molecules and other molecules associated with plants |
US6740526B1 (en) * | 1999-09-22 | 2004-05-25 | Wayne R. Curtis | Quantitative transient protein expression in plant tissue culture |
US7553954B2 (en) * | 1999-09-22 | 2009-06-30 | Monsanto Technology Llc | Nucleic acid molecules and other molecules associated with plants |
US6573426B1 (en) * | 1999-09-30 | 2003-06-03 | E.I. Du Pont De Nemours & Company | Gene involved in pyrimidine biosynthesis in plants |
US20070016974A1 (en) * | 1999-09-30 | 2007-01-18 | Byrum Joseph R | Nucleic acid molecules and other molecules associated with plants |
WO2001055169A1 (en) * | 2000-01-27 | 2001-08-02 | Loma Linda University | Transgenic plant-based vaccines |
US6703540B1 (en) * | 2000-03-09 | 2004-03-09 | The United States Of America As Represented By The Secretary Of Agriculture | Transformation of plants with a chloroperoxidase gene to enhance disease resistance |
US20070083945A1 (en) * | 2000-03-10 | 2007-04-12 | Byrum Joseph R | Nucleic acid molecules and other molecules associated with plants |
US6770799B2 (en) * | 2000-03-17 | 2004-08-03 | Thompson Boyce Plant Res | Expression of recombinant human acetylcholinesterase in transgenic plants |
FR2809416B1 (en) * | 2000-05-29 | 2004-12-10 | Tabacs & Allumettes Ind | CLONING AND SEQUENCING OF DAC G5 ALLERGEN FROM DACTILYS GLOMERATA POLLEN, ITS PREPARATION AND ITS USE |
AU2001267189A1 (en) * | 2000-06-05 | 2001-12-17 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri Food Canada | Recombinant subunit proteins from porcine parvovirus produced in plants |
EP1296710A4 (en) * | 2000-06-19 | 2004-05-12 | Rahan Meristem | Recombinant vaccines against infectious bursal disease virus |
AR030430A1 (en) * | 2000-06-29 | 2003-08-20 | Sungene Gmbh & Co Kgaa | PROCEDURE FOR THE OBTAINING OF FINE CHEMICALS BY CULTURE OF ORGANISMS THAT PRESENT A MODIFIED SHIQUIMATE ROUTE, NUCLEINIC ACID COMPOSITION, USE OF SUCH NUCLEINIC ACID FOR THE OBTAINING OF TRANSGENIC PLANTS, GENETICALLY PRODUCED PROCEDURE ORGANISM |
ES2640613T3 (en) * | 2000-07-21 | 2017-11-03 | Revance Therapeutics, Inc. | Multi-component biological agent transport systems |
US20040010817A1 (en) * | 2000-07-21 | 2004-01-15 | Washington State University Research Foundation | Plant acyl-CoA synthetases |
US7632983B2 (en) * | 2000-07-31 | 2009-12-15 | Biolex Therapeutics, Inc. | Expression of monoclonal antibodies in duckweed |
CA2417415C (en) | 2000-07-31 | 2012-10-09 | Biolex, Inc. | Expression of biologically active polypeptides in duckweed |
US7959910B2 (en) | 2000-07-31 | 2011-06-14 | Biolex Therapeutics, Inc. | C-terminally truncated interferon alpha variants |
US8022270B2 (en) * | 2000-07-31 | 2011-09-20 | Biolex Therapeutics, Inc. | Expression of biologically active polypeptides in duckweed |
US20060265782A1 (en) * | 2000-08-29 | 2006-11-23 | Hinkle Gregory J | Novel plant transcribed regions and uses thereof |
US20070067865A1 (en) * | 2000-09-05 | 2007-03-22 | Kovalic David K | Annotated plant genes |
US6784341B2 (en) * | 2000-09-14 | 2004-08-31 | Pioneer Hi-Bred International, Inc. | Defense-related signaling genes and methods of use |
WO2002043650A2 (en) * | 2000-11-28 | 2002-06-06 | Virogene Ltd. | Systems and methods for delivering interferon to a subject |
US20060064782A1 (en) * | 2000-12-18 | 2006-03-23 | Conopco, Inc. | Production of antibodies |
US6806401B2 (en) * | 2000-12-27 | 2004-10-19 | Pioneer Hi-Bred International, Inc. | OAR polynucleotides, polypeptides and their use in PHA production in plants |
WO2002067663A1 (en) * | 2001-02-27 | 2002-09-06 | Multigenesis Corporation | Methods for effectuating mrna-mediated transfer of genetic information into plants and products of the same |
CN1541059A (en) * | 2001-03-06 | 2004-10-27 | �Ϻ���ͨ��ѧ | Plant cell having animal-type sugar chain adding function |
US20030033637A1 (en) * | 2001-06-05 | 2003-02-13 | Croptech Corporation | Gene expression and production of TGF-beta proteins including bioactive mullerian inhibiting substance from plants |
JP2004535192A (en) * | 2001-06-08 | 2004-11-25 | イコン ジェネティクス インコーポレイティッド | Production of proteins in plants |
ITRM20010332A1 (en) * | 2001-06-11 | 2002-12-11 | Ist Superiore Sanita | SUBUNITY VACCINES AND PROCEDURES FOR THEIR PRODUCTION. |
WO2003012035A2 (en) * | 2001-07-27 | 2003-02-13 | Icon Genetics, Inc. | Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins |
US20090158452A1 (en) * | 2001-12-04 | 2009-06-18 | Johnson Richard G | Transgenic plants with enhanced agronomic traits |
US20030217384A1 (en) * | 2002-02-05 | 2003-11-20 | Harvell Leslie T. | Obtusifoliol 14a-demethylase |
WO2003072750A2 (en) * | 2002-02-27 | 2003-09-04 | Prodigene, Inc. | Expression of hiv-related proteins in plants |
WO2003073982A2 (en) * | 2002-02-28 | 2003-09-12 | Eli Lilly And Company | Anti-interleukin-1 beta analogs |
AU2003213815A1 (en) * | 2002-03-08 | 2003-09-22 | Prodigene, Inc. | Production of insulin and insulin-like proteins in plants |
US7238854B2 (en) * | 2002-04-11 | 2007-07-03 | E. I. Du Pont De Nemours And Company | Method of controlling site-specific recombination |
US6776751B2 (en) * | 2002-04-22 | 2004-08-17 | Kendor Laboratory Products, Lp | Rotor cover attachment apparatus |
WO2004005343A1 (en) * | 2002-07-02 | 2004-01-15 | Nexgen Biotechnologies, Inc. | Production of transformed plants expressing thyroid stimulating hormone receptor |
CA2491639A1 (en) * | 2002-07-03 | 2004-01-15 | University Of Central Florida | Expression of the human igf-1 in transgenic plastids |
WO2004013304A2 (en) * | 2002-08-02 | 2004-02-12 | Basf Plant Science Gmbh | Sugar and lipid metabolism regulators in plants iv |
US6920521B2 (en) * | 2002-10-10 | 2005-07-19 | International Business Machines Corporation | Method and system of managing virtualized physical memory in a data processing system |
WO2004044161A2 (en) * | 2002-11-06 | 2004-05-27 | Fraunhofer Usa | Expression of foreign sequences in plants using trans-activation system |
US7683238B2 (en) * | 2002-11-12 | 2010-03-23 | iBio, Inc. and Fraunhofer USA, Inc. | Production of pharmaceutically active proteins in sprouted seedlings |
US7692063B2 (en) * | 2002-11-12 | 2010-04-06 | Ibio, Inc. | Production of foreign nucleic acids and polypeptides in sprout systems |
TWI350310B (en) | 2002-12-13 | 2011-10-11 | Novartis Ag | Immunization of fish with plant-expressed recombinant proteins |
EP2192172B1 (en) * | 2003-02-03 | 2014-12-03 | iBio, Inc. | System for expression of genes in plants |
US20040173547A1 (en) * | 2003-03-06 | 2004-09-09 | Roth Michael Carl | Bolt on attachment to facilitate hanging of pneumatic tool |
KR100546066B1 (en) * | 2003-03-21 | 2006-01-26 | 한국생명공학연구원 | The transformed plant cell expressing tandem repeats of ?-amyloid gene and plant produced by the same |
US20040216190A1 (en) * | 2003-04-28 | 2004-10-28 | Kovalic David K. | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
US20060252120A1 (en) * | 2003-05-09 | 2006-11-09 | Kieliszewski Marcia J | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
DK1633876T3 (en) * | 2003-06-17 | 2008-12-08 | Sembiosys Genetics Inc | Process for producing insulin in plants |
TW200526778A (en) * | 2003-11-14 | 2005-08-16 | Sembiosys Genetics Inc | Methods for the production of apolipoproteins in transgenic plants |
CA2553257A1 (en) * | 2004-01-14 | 2005-08-04 | Ohio University | Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
WO2005081905A2 (en) | 2004-02-20 | 2005-09-09 | Fraunhofer Usa Inc. | Systems and methods for clonal expression in plants |
WO2005089471A2 (en) * | 2004-03-17 | 2005-09-29 | University Of Florida Research Foundation, Inc | Increased stress tolerance and enhanced yield in plants |
US8623812B2 (en) | 2004-04-19 | 2014-01-07 | Ohio University | Cross-linkable glycoproteins and methods of making the same |
WO2005115130A2 (en) * | 2004-05-24 | 2005-12-08 | The State Of Israel - Ministry Of Agriculture & Rural Development, Agricultural Research Organization | Transgenic ficus, method for producing same and use thereof |
US20060024272A1 (en) * | 2004-07-29 | 2006-02-02 | Large Scale Biology Corporation | C-terminally truncated interferon |
BRPI0514251A (en) * | 2004-08-11 | 2008-06-03 | Basf Plant Science Gmbh | Methods for Producing a Transgenic Plant Having a Modified Level of a Seed Storage Compound, and for Modulating a Level of a Seed Storage Compound on a Plant, Transgenic Plant, Seed, Seed Oil, and Isolated Nucleic Acid |
DE602005015473D1 (en) | 2004-09-23 | 2009-08-27 | Bayer Cropscience Ag | METHOD AND MEANS FOR PRODUCING HYALURONANE |
US7582817B2 (en) * | 2005-03-23 | 2009-09-01 | E.I. Du Pont De Nemours And Company | Alteration of plant embryo/endosperm size during development |
WO2007008708A2 (en) * | 2005-07-08 | 2007-01-18 | Ohio University | Methods of predicting hyp-glycosylation sites for proteins expressed and secreted in plant cells, and related methods and products |
US8993846B2 (en) * | 2005-09-06 | 2015-03-31 | Monsanto Technology Llc | Vectors and methods for improved plant transformation efficiency |
KR20200054317A (en) * | 2007-02-09 | 2020-05-19 | 악셀레론 파마 인코포레이티드 | Activin-actriia antagonists and uses for promoting bone growth in cancer patients |
WO2008121154A2 (en) * | 2007-03-31 | 2008-10-09 | Rutgers, The State University Of New Jersey | Nucleic acid sequences for biosynthesis of non -mccj25-related lariat peptides |
AU2010321676B2 (en) | 2009-11-18 | 2015-02-26 | Agriculture Victoria Services Pty Ltd | Angiogenin expression in plants |
US10150970B2 (en) | 2011-07-27 | 2018-12-11 | Applied Biotechnology Institute, Inc. | Methods to increase antigenicity of membrane-bound polypeptides produced in plants |
US20170191041A1 (en) * | 2014-07-11 | 2017-07-06 | Biostrategies LC | Materials and methods for treating disorders associated with sulfatase enzymes |
US11344835B2 (en) | 2018-08-21 | 2022-05-31 | Donaldson Company, Inc. | Filter assembly for an enclosure |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4399216A (en) * | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
EP0108580A1 (en) * | 1982-11-08 | 1984-05-16 | Amoco Corporation | Method for introducing foreign genes into green algae utilizing T-DNA of agrobacterium |
US4530901A (en) * | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS215108B2 (en) * | 1977-07-15 | 1982-07-30 | Wellcome Found | Method of making the interferrone |
US4278661A (en) * | 1979-10-12 | 1981-07-14 | E. I. Du Pont De Nemours And Company | Purification of interferon |
IL66614A (en) * | 1981-08-28 | 1985-09-29 | Genentech Inc | Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it |
JPH0787797B2 (en) * | 1982-05-20 | 1995-09-27 | サントリー株式会社 | Method for producing human gamma interferon-like polypeptide |
IL69382A (en) * | 1982-08-05 | 1991-01-31 | Carter William Alvin | Method of protecting plants against viral pathogens by inserting into plant cells genes encoding polypeptides containing interferon domains |
EP0131623B2 (en) * | 1983-01-17 | 1999-07-28 | Monsanto Company | Chimeric genes suitable for expression in plant cells |
WO1984002919A1 (en) * | 1983-01-17 | 1984-08-02 | Monsanto Co | Plasmids for transforming plant cells |
SU1582990A3 (en) * | 1983-01-17 | 1990-07-30 | Монсанто Компани (Фирма) | Method of producing transformed cells of dicetyledonous plant |
US5102796A (en) * | 1983-04-15 | 1992-04-07 | Lubrizol Genetics, Inc. | Plant structural gene expression |
CA1278540C (en) * | 1983-07-22 | 1991-01-02 | Eli Lilly And Company | Modified antibiotic resistance gene |
IL72666A0 (en) * | 1983-08-15 | 1984-11-30 | Stauffer Chemical Co | Plasmid vector |
US4771002A (en) * | 1984-02-24 | 1988-09-13 | Lubrizol Genetics, Inc. | Transcription in plants and bacteria |
EP0179861A1 (en) * | 1984-04-19 | 1986-05-07 | Agracetus | Methods and vectors for transformation of plant cells |
AU6137986A (en) * | 1985-07-16 | 1987-02-10 | Salk Institute For Biological Studies, The | Genetic alteration of plants with retroviruses |
US4956282A (en) * | 1985-07-29 | 1990-09-11 | Calgene, Inc. | Mammalian peptide expression in plant cells |
NL8901932A (en) * | 1989-07-26 | 1991-02-18 | Mogen Int | PRODUCTION OF heterologous PROTEINS IN PLANTS OR PLANTS. |
IT1264083B1 (en) * | 1993-12-10 | 1996-09-10 | Enea Ente Nuove Tec | PROCEDURE FOR THE PRODUCTION IN PLANTS OF ENGINEERED ANTIBODY, PRODUCED ANTIBODY AND THEIR USE IN DIAGNOSIS AND THERAPY. |
-
1985
- 1985-07-29 US US06/760,236 patent/US4956282A/en not_active Expired - Lifetime
-
1986
- 1986-07-29 CA CA000514891A patent/CA1340696C/en not_active Expired - Lifetime
- 1986-07-29 EP EP86905070A patent/EP0233915B1/en not_active Revoked
- 1986-07-29 JP JP61504417A patent/JPS63500425A/en active Pending
- 1986-07-29 AU AU61966/86A patent/AU603063B2/en not_active Expired
- 1986-07-29 AT AT86905070T patent/ATE85361T1/en not_active IP Right Cessation
- 1986-07-29 WO PCT/US1986/001599 patent/WO1987000865A1/en not_active Application Discontinuation
- 1986-07-29 DE DE8686905070T patent/DE3687705T2/en not_active Revoked
-
1993
- 1993-12-08 US US08/164,346 patent/US5550038A/en not_active Expired - Fee Related
-
1995
- 1995-06-05 US US08/463,182 patent/US5629175A/en not_active Expired - Fee Related
-
1998
- 1998-07-31 US US09/127,174 patent/US6096547A/en not_active Expired - Fee Related
-
1999
- 1999-04-07 US US09/287,447 patent/US20010049830A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4530901A (en) * | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
US4399216A (en) * | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
EP0108580A1 (en) * | 1982-11-08 | 1984-05-16 | Amoco Corporation | Method for introducing foreign genes into green algae utilizing T-DNA of agrobacterium |
Non-Patent Citations (4)
Title |
---|
A. DEPICKER et al., "Plant Cell Transformation by Agrobacterium Plasmids" in Genetic Engineering of Plants-An Agricultural Perspective, 1983, Plenum Press (New York, New York), see pages 144 to 148. * |
Gene, Volume 23, issued September, 1983, (Amsterdam, Holland), C.H. SHAW et al. "A General Method for the Transfer of Cloned Genes to Plant Cells", pages 315-330. * |
Proceedings of the National Academy Sciences USA, Volume 80, issued August, 1983, (Washington, D.C.), R. T. FRALEY et al., "Expression of Bacterial Genes in Plant Cells" pages 4803-4807. * |
See also references of EP0233915A4 * |
Cited By (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0204590A3 (en) * | 1985-04-22 | 1988-09-21 | Institut National De La Recherche Agronomique (Inra) | T-dna promoters of the ri plasmid |
EP0204590A2 (en) * | 1985-04-22 | 1986-12-10 | Institut National De La Recherche Agronomique (Inra) | T-DNA promoters of the Ri plasmid |
EP0289478A3 (en) * | 1987-04-27 | 1990-10-24 | Monsanto Company | Gentamicin marker genes for plant transformation |
EP0289478A2 (en) * | 1987-04-27 | 1988-11-02 | Monsanto Company | Gentamicin marker genes for plant transformation |
EP0319353A1 (en) * | 1987-10-20 | 1989-06-07 | Plant Genetic Systems N.V. | A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants |
US5487991A (en) * | 1987-10-20 | 1996-01-30 | Plant Genetic Systems N.V. | Process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants |
EP0318341A1 (en) * | 1987-10-20 | 1989-05-31 | Plant Genetic Systems, N.V. | A process for the production of transgenic plants with increased nutritional value via the expression of modified 2S storage albumins in said plants |
EP0723019A1 (en) * | 1987-10-20 | 1996-07-24 | Plant Genetic Systems N.V. | A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants |
WO1989003887A1 (en) * | 1987-10-20 | 1989-05-05 | Plant Genetic Systems N.V. | A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants |
US5623067A (en) * | 1987-10-20 | 1997-04-22 | Plant Genetic Systems, N.V. | Seed-specific promoter region |
US5677474A (en) * | 1988-07-29 | 1997-10-14 | Washington University | Producing commercially valuable polypeptides with genetically transformed endosperm tissue |
WO1990001551A1 (en) * | 1988-07-29 | 1990-02-22 | Washington University School Of Medicine | Producing commercially valuable polypeptides with genetically transformed endosperm tissue |
US5686079A (en) * | 1988-09-06 | 1997-11-11 | Washington University | Oral immunization by transgenic plants |
US5679880A (en) * | 1988-09-06 | 1997-10-21 | Washington University | Oral immunization by transgenic plants |
US5654184A (en) * | 1988-09-06 | 1997-08-05 | Washington University | Oral immunization by transgenic plants |
AU634178B2 (en) * | 1988-09-06 | 1993-02-18 | Washington University | Oral immunization by transgenic plants |
WO1990002484A1 (en) * | 1988-09-06 | 1990-03-22 | Washington University | Oral immunization by transgenic plants |
US5589615A (en) * | 1988-10-14 | 1996-12-31 | Plant Genetic Systems N.V. | Process for the production of transgenic plants with increased nutritional value via the expression of modified 2S storage albumins |
US5428146A (en) * | 1988-11-07 | 1995-06-27 | Max-Planck-Gesellschaft Zur Forderung | Wound-stimulated DNA-sequence from solanum tuberosum and its use |
AU628962B2 (en) * | 1989-04-10 | 1992-09-24 | Medex, Inc. | Catheter with needle guard |
US5716802A (en) * | 1989-07-26 | 1998-02-10 | Mogen International, N.V. | Production of heterologous proteins in plants and plant cells |
US5763748A (en) * | 1989-07-26 | 1998-06-09 | Mogen International N.V. | Production of heterologous protein in plants and plant cells |
WO1991002066A1 (en) * | 1989-07-26 | 1991-02-21 | Mogen International N.V. | Production of heterologous proteins in plants and plant cells |
US7282625B2 (en) | 1989-10-27 | 2007-10-16 | The Scripps Research Institute | Method of producing single chain protein in plant cells |
US5202422A (en) * | 1989-10-27 | 1993-04-13 | The Scripps Research Institute | Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use |
WO1991006320A1 (en) * | 1989-10-27 | 1991-05-16 | Scripps Clinic And Research Foundation | Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
US6995014B1 (en) | 1989-10-27 | 2006-02-07 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
EP1048734A2 (en) * | 1989-10-27 | 2000-11-02 | The Scripps Research Institute | Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
US7101688B2 (en) | 1989-10-27 | 2006-09-05 | The Scripps Research Institute | Method of producing heteromultimeric mammalian proteins in plants |
US7037722B1 (en) | 1989-10-27 | 2006-05-02 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
US5639947A (en) * | 1989-10-27 | 1997-06-17 | The Scripps Research Institute | Compositions containing glycopolypeptide multimers and methods of making same in plants |
US5959177A (en) * | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
US6852319B2 (en) | 1989-10-27 | 2005-02-08 | The Scripps Research Institue | Method of use of transgenic plant expressed antibodies |
EP1048734A3 (en) * | 1989-10-27 | 2001-11-28 | The Scripps Research Institute | Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
WO1991013993A1 (en) * | 1990-03-05 | 1991-09-19 | The Upjohn Company | Protein expression via seed specific regulatory sequences |
WO1991014772A1 (en) * | 1990-03-23 | 1991-10-03 | Gist-Brocades N.V. | Production of enzymes in seeds and their use |
US5714474A (en) * | 1990-03-23 | 1998-02-03 | Mogen International | Production of enzymes in seeds and their use |
EP0449375A2 (en) * | 1990-03-23 | 1991-10-02 | Gist-Brocades N.V. | The expression of phytase in plants |
US7033627B2 (en) | 1990-03-23 | 2006-04-25 | Syngenta Mogen B.V. | Production of enzymes in seeds and their use |
EP0449376A2 (en) * | 1990-03-23 | 1991-10-02 | Gist-Brocades N.V. | Production of enzymes in seeds and their use |
WO1991014782A1 (en) * | 1990-03-23 | 1991-10-03 | Gist-Brocades N.V. | The expression of phytase in plants |
EP0449375A3 (en) * | 1990-03-23 | 1991-10-09 | Gist-Brocades N.V. | The expression of phytase in plants |
EP0449376A3 (en) * | 1990-03-23 | 1991-11-06 | Gist Brocades Nv | Production of enzymes in seeds and their use |
US5543576A (en) * | 1990-03-23 | 1996-08-06 | Mogen International | Production of enzymes in seeds and their use |
AU632941B2 (en) * | 1990-03-23 | 1993-01-14 | Gist-Brocades N.V. | The expression of phytase in plants |
WO1992001042A1 (en) * | 1990-07-06 | 1992-01-23 | Novo Nordisk A/S | Transgenic plants expressing industrial enzymes |
US5593963A (en) * | 1990-09-21 | 1997-01-14 | Mogen International | Expression of phytase in plants |
US7504560B2 (en) | 1991-08-26 | 2009-03-17 | Prodigene, Inc. | Vaccines expressed in plants |
US6136320A (en) * | 1991-08-26 | 2000-10-24 | Prodigene, Inc. | Vaccines expressed in plants |
US5484719A (en) * | 1991-08-26 | 1996-01-16 | Edible Vaccines, Inc. | Vaccines produced and administered through edible plants |
WO1999009187A1 (en) * | 1995-05-16 | 1999-02-25 | Lefaivre Francis E | Large scale production of human or animal proteins using plant bioreactors |
US5981835A (en) * | 1996-10-17 | 1999-11-09 | Wisconsin Alumni Research Foundation | Transgenic plants as an alternative source of lignocellulosic-degrading enzymes |
WO1998021348A1 (en) * | 1996-11-12 | 1998-05-22 | Battelle Memorial Institute | Method of producing human growth factors from whole plants or plant cell cultures |
US6818803B1 (en) | 1997-06-26 | 2004-11-16 | Wisconsin Alumni Research Foundation | Transgenic plants as an alternative source of lignocellulosic-degrading enzymes |
US8241909B2 (en) | 1998-12-09 | 2012-08-14 | Phyton Holdings, Llc | Method for manufacturing glycoproteins having human-type glycosylation |
US8853370B2 (en) | 1998-12-09 | 2014-10-07 | Phyton Holdings, Llc | Plant-produced glycoprotein comprising human-type sugar chain |
US8193415B2 (en) | 1999-10-26 | 2012-06-05 | Stichting Dienst Landbouwkundig Onderzock | Plant expressing mammalian β1,4-galactosyltransferase and β1,3-glucuronyltransferase |
US7781647B2 (en) | 1999-10-26 | 2010-08-24 | Stichting Dienst Landbouwkundig Onderzoek | Mammalian-type glycosylation in transgenic plants expressing mammalian β1,4-galactosyltransferase |
US8907163B2 (en) | 1999-10-26 | 2014-12-09 | Stichting Dienst Landbouwkundig Onderzoek | Transgenic plants expressing galactosyltransferase and sialyl transferase |
WO2001031044A1 (en) * | 1999-10-26 | 2001-05-03 | Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. | Gonadotrophins in plants |
EP1772518A3 (en) * | 1999-10-26 | 2007-04-18 | Plant Research International B.V. | Mammalian-type glycosylation in plants |
WO2001042441A3 (en) * | 1999-12-08 | 2002-01-03 | Icgeb | Plastid transformation |
WO2001042441A2 (en) * | 1999-12-08 | 2001-06-14 | International Centre For Genetic Engineering And Biotechnology | Plastid transformation |
US6696620B2 (en) | 2000-05-02 | 2004-02-24 | Epicyte Pharmaceutical, Inc. | Immunoglobulin binding protein arrays in eukaryotic cells |
US8735656B2 (en) | 2001-01-19 | 2014-05-27 | Phyton Holdings, Llc | Method of expressing galactosyltransferase and inhibiting xylosyltransferase or fucosyltransferase in a transgenic plant cell for secretory production of glycoproteins having human-type sugar chains |
US8309795B2 (en) | 2001-01-19 | 2012-11-13 | Phyton Holdings, Llc | Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
US9574218B2 (en) | 2001-01-19 | 2017-02-21 | Phyton Holdings, Llc | Method of co-expressing galactosyltransferase and a glycoprotein in a transgenic plant cell and sialylating the glycoprotein for production of glycoprotein having human-type sugar chain |
US7601891B2 (en) | 2002-03-19 | 2009-10-13 | Plant Research International B.V. | Optimizing glycan processing plants |
US8492613B2 (en) | 2002-03-19 | 2013-07-23 | Stichting Dienst Landbouwkundig Onderzoek | GNTIII expression in plants |
US8058508B2 (en) | 2002-03-19 | 2011-11-15 | Stichting Dienst Landbouwkundig Onderzoek | Optimizing glycan processing in plants |
US8927810B2 (en) | 2002-03-19 | 2015-01-06 | Stichting Dienst Landbouwkundig Onderzoek | Optimizing glycan processing in plants |
US9255277B2 (en) | 2002-03-19 | 2016-02-09 | Stichting Dienst Landbouwkundig Onderzoek | GNTIII expression in plants |
US8106169B2 (en) | 2002-11-27 | 2012-01-31 | Phyton Holdings, Llc | Plant production of immunoglobulins with reduced fucosylation |
WO2006005362A1 (en) * | 2004-07-13 | 2006-01-19 | Paion Deutschland Gmbh | Production of mammalian proteins in plant cells |
US8829276B2 (en) | 2007-04-17 | 2014-09-09 | Stichting Dienst Landbouwkundig Onderzoek | Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases |
US9745594B2 (en) | 2007-04-17 | 2017-08-29 | Stichting Dienst Landbouwkundig Onderzoek | Mammalian-type glycosylation in plants by expression of a zebrafish glycosyltransferase |
Also Published As
Publication number | Publication date |
---|---|
EP0233915A1 (en) | 1987-09-02 |
DE3687705D1 (en) | 1993-03-18 |
AU6196686A (en) | 1987-03-05 |
EP0233915A4 (en) | 1988-03-23 |
US5550038A (en) | 1996-08-27 |
CA1340696C (en) | 1999-08-10 |
US20010049830A1 (en) | 2001-12-06 |
AU603063B2 (en) | 1990-11-08 |
ATE85361T1 (en) | 1993-02-15 |
EP0233915B1 (en) | 1993-02-03 |
US5629175A (en) | 1997-05-13 |
US4956282A (en) | 1990-09-11 |
JPS63500425A (en) | 1988-02-18 |
US6096547A (en) | 2000-08-01 |
DE3687705T2 (en) | 1993-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1340696C (en) | Mammalian peptide expression in plant cells | |
US6774283B1 (en) | Molecular farming | |
RU2148647C1 (en) | Method of expression of interesting dna sequence in seed cell, dna-structure, expression cassette, isolated regulatory site of transcription and method of alternation of specific metabolism in seeds | |
US5315001A (en) | Acyl carrier protein - DNA sequence and synthesis | |
US8063269B2 (en) | Transgenic plants with reduced level of saturated fatty acid and methods for making them | |
Yang et al. | Expression of a synthetic gene for improved protein quality in transformed potato plants | |
WO1997004122A1 (en) | Production of secreted foreign polypeptides in plant cell culture | |
ZA200103557B (en) | Novel expression cassette for expressing genes in plant seed. | |
WO1985004899A1 (en) | Methods and vectors for transformation of plant cells | |
EP0573767B1 (en) | Process for production of exogenous gene or its product in plant cells | |
CN102851306B (en) | For the production of the transgenic aloe plants of albumen and relevant method thereof | |
Zhang et al. | Expression and production of bioactive human interleukin-18 in transgenic tobacco plants | |
CN105980561B (en) | CPMV enhancer element | |
EP0754757A2 (en) | A plant promoter and an application thereof | |
JPH03501680A (en) | Cucumber mosaic virus coat protein gene | |
US20040117874A1 (en) | Methods for accumulating translocated proteins | |
WO1997042315A1 (en) | Transgenic plants resistant to geminivirus infection | |
JP7184233B2 (en) | Gene Constructs for Recombinant Protein Expression Containing a Lettuce Ubiquitin Promoter | |
KR100974302B1 (en) | Fetuin producing potato plant | |
US7329798B2 (en) | Harvest-inducible regulatory elements and methods of using same | |
KR20050027838A (en) | Recombinant human growth hormone expressed in plants | |
KR20230135411A (en) | High expression vector containing recombinated strong promoter and/or terminator for high amount of target protein in plants and method for mass producing target protein using the same | |
KR20050027836A (en) | Basic fibroblast growth factor expressed in plants | |
KR20050027839A (en) | Human granulocyte macrophage colony stimulating factor expressed in plants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1986905070 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1986905070 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1986905070 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1986905070 Country of ref document: EP |